<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wise HM</submitter><funding>Intramural NIH HHS</funding><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>e1002998</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3486900</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(11)</volume><pubmed_abstract>Segment 7 of influenza A virus produces up to four mRNAs. Unspliced transcripts encode M1, spliced mRNA2 encodes the M2 ion channel, while protein products from spliced mRNAs 3 and 4 have not previously been identified. The M2 protein plays important roles in virus entry and assembly, and is a target for antiviral drugs and vaccination. Surprisingly, M2 is not essential for virus replication in a laboratory setting, although its loss attenuates the virus. To better understand how IAV might replicate without M2, we studied the reversion mechanism of an M2-null virus. Serial passage of a virus lacking the mRNA2 splice donor site identified a single nucleotide pseudoreverting mutation, which restored growth in cell culture and virulence in mice by upregulating mRNA4 synthesis rather than by r</pubmed_abstract><journal>PLoS pathogens</journal><pubmed_title>Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain.</pubmed_title><pmcid>PMC3486900</pmcid><funding_grant_id>088789</funding_grant_id><funding_grant_id>BBS/E/D/20241864</funding_grant_id><funding_grant_id>075450</funding_grant_id><funding_grant_id>G0700815</funding_grant_id><funding_grant_id>G0700848</funding_grant_id><funding_grant_id>G0801931</funding_grant_id><pubmed_authors>Stuart AD</pubmed_authors><pubmed_authors>Hutchinson EC</pubmed_authors><pubmed_authors>Kang ZH</pubmed_authors><pubmed_authors>Wise HM</pubmed_authors><pubmed_authors>Digard P</pubmed_authors><pubmed_authors>Fodor E</pubmed_authors><pubmed_authors>Taubenberger JK</pubmed_authors><pubmed_authors>Jagger BW</pubmed_authors><pubmed_authors>Kash JC</pubmed_authors><pubmed_authors>Schwartzman LM</pubmed_authors><pubmed_authors>Firth AE</pubmed_authors><pubmed_authors>Gog JR</pubmed_authors><pubmed_authors>Robb N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain.</name><description>Segment 7 of influenza A virus produces up to four mRNAs. Unspliced transcripts encode M1, spliced mRNA2 encodes the M2 ion channel, while protein products from spliced mRNAs 3 and 4 have not previously been identified. The M2 protein plays important roles in virus entry and assembly, and is a target for antiviral drugs and vaccination. Surprisingly, M2 is not essential for virus replication in a laboratory setting, although its loss attenuates the virus. To better understand how IAV might replicate without M2, we studied the reversion mechanism of an M2-null virus. Serial passage of a virus lacking the mRNA2 splice donor site identified a single nucleotide pseudoreverting mutation, which restored growth in cell culture and virulence in mice by upregulating mRNA4 synthesis rather than by r</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2025-07-09T03:05:08.388Z</modification><creation>2025-07-09T03:05:08.388Z</creation></dates><accession>S-EPMC3486900</accession><cross_references><pubmed>23133386</pubmed><doi>10.1371/journal.ppat.1002998</doi></cross_references></HashMap>